SEC Info - Versant Venture Capital VI, L.P., et al. - ‘4/A’ for 1/7/20 re: Akero Therapeutics, Inc.

SEC Info℠

Home

Help

Please Sign In

Versant Venture Capital VI, L.P., et al. – ‘4/A’ for 1/7/20 re: Akero Therapeutics, Inc.

On: Friday, 7/10/20, at 8:28pm ET · For: 1/7/20 · Accession #: 1104659-20-82855 · File #: 1-38944

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/10/20  Versant Venture Capital VI, L.P.  4/A                    1:12K  Akero Therapeutics, Inc.          Toppan Merrill/FA
          Versant Ventures VI GP, L.P.
          Versant Ventures VI GP-GP, LLC

Amendment to Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4/A         Amendment to Statement of Changes in Beneficial     HTML      3K 
                Ownership of Securities by an Insider --                         
                a4a.xml/3.6

Filing Submission 0001104659-20-082855 – SGML Text

Original SGML Text submitted by:	Toppan Merrill/FA (as Filing Agent)

To view the SGML, please refresh
this page.

↑Top

Versant Venture Capital VI, L.P., et al. – ‘4/A’ for 1/7/20 re: Akero Therapeutics, Inc.

On: Friday, 7/10/20, at 8:28pm ET · For: 1/7/20 · Accession #: 1104659-20-82855 · File #: 1-38944

Previous ‘4’: ‘4/A’ on 7/10/20 for 1/2/20 · Next: ‘4’ on / for 7/21/20 · Latest: ‘4’ on 4/11/24 for 4/9/24

Amendment to Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34Filing Table of Contents

To view the SGML, please refresh this page.

Amendment to Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34
Filing Table of Contents

To view the SGML, please refresh
this page.